Vancouver, British Columbia –
May 13, 2022.
Lexston Life Sciences Corp.
) (CSE:LEXT) (OTC:LEXTF)
announces that its board of directors approved
the consolidation of the common shares of the Company on the ratio of
five (5) pre-consolidated shares for one (1) post-consolidated share.
The effective date and timing of the share consolidation will be
determined and announced at a later date.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
The Canadian Securities Exchange has
not reviewed and does not accept responsibility for the adequacy or
accuracy of the content of this news release.
Copyright (c) 2022 TheNewswire – All rights reserved.